|
10 However, to maintain effective protection against pregnancy, another method of contraception must be used as soon as menstruation resumes, the frequency or duration of breastfeeds is reduced, bottle feeds are introduced, or the baby reaches six months of age. ORTHO EVRA® has not been studied for and is not indicated for use in emergency contraception. DOSAGE AND ADMINISTRATION Text Continues Below
To achieve maximum contraceptive effectiveness, ORTHO EVRA® must be used exactly as directed. Complete instructions to facilitate patient counseling on proper system usage may be found in the Detailed Patient Labeling. Transdermal Contraceptive System Overview This system uses a 28-day (four-week) cycle. A new patch is applied each week for three weeks (21 total days). Week Four is patch-free. Withdrawal bleeding is expected during this time. Every new patch should be applied on the same day of the week. This day is known as the “Patch Change Day.” For example, if the first patch is applied on a Monday, all subsequent patches should be applied on a Monday. Only one patch should be worn at a time. On the day after Week Four ends a new four-week cycle is started by applying a new patch. Under no circumstances should there be more than a seven-day patch-free interval between dosing cycles. If the woman is starting ORTHO EVRA® for the first time, she should wait until the day she begins her menstrual period. Either a First Day start or Sunday start may be chosen (see below). The day she applies her first patch will be Day 1. Her “Patch Change Day” will be on this day every week. • for First Day Start: the patient should apply her first patch during the first 24 hours of her menstrual period. If therapy starts after Day 1 of the menstrual cycle, a non-hormonal back-up contraceptive (such as a condoms, spermicide, or diaphragm) should be used concurrently for the first 7 consecutive days of the first treatment cycle.
OR Page: << Prev | 1 | 2 | 3 | 4 | 5 | Next >>
|
.gif)
